483 Mylan Labs Limited (Sterile Products Division) Mar 2018

483 Mylan Labs Limited (Sterile Products Division) Mar 2018

Michael Charles FDA$119.00 - Available Now

FDA investigators audited the Mylan Labs Limited (Sterile Products Division) - Bangalore, India facility and issued inspectional observations (via FDA 483) on 13 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Mar 2018
  • Location: Bangalore, India
  • FEI: 3003813519
Add To Cart